No 04 2016

In 2023, there were an estimated 263 million malaria cases, and 597,000 malaria deaths, making it a prioritized field for many researchers around the world. In Umeå, Sweden, Professor Oliver Billker’s group is focusing on the basic biology of the parasite, with the goal to develop new drugs and vaccines and understand why some mosquito species transmit malaria while others do not.

Leon Wyszkowski, president of analytical services for clinical research, has received the Key to Gothenburg, on behalf of Thermo Fisher during a ceremony at the City Hall.

Hansa Biopharma has announced the appointment of Renée Aguiar-Lucander as Chief Executive Officer (CEO), effective immediately.

The European Patent Office, EPO, has issued a decision to grant European patent for exidavnemab, a drug candidate being developed as a treatment for synucleinopathies such as Parkinson’s disease and Multiple System Atrophy (MSA).

Euro-BioImaging Finland, the research infrastructure of Finnish bioimaging, has received funding of about EUR 28 million from the Research Council of Finland.

A DKK  200 million grant from the Novo Nordisk Foundation will enable a new national “one point of entry” gateway to health data to be established in Denmark.

The Unites States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application with claims covering a method of treating rheumatoid arthritis (RA) with resomelagon (AP1189) in combination with methotrexate (MTX).